Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

Anita Katharina Wagner, D.P.H., Dr.Pharm.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Hughes TM, Empringham B, Wagner AK, Ward ZJ, Yeh J, Gupta S, Frazier AL, Denburg AE. Forecasting essential childhood cancer drug need: An innovative model-based approach. Cancer. 2021 Apr 12. PMID: 33844270.
    Citations:    Fields:    
  2. Darrow JJ, Sharma M, Shroff M, Wagner AK. Efficacy and costs of spinal muscular atrophy drugs. Sci Transl Med. 2020 11 11; 12(569). PMID: 33177183.
    Citations: 2     Fields:    
  3. Ferrario A, Xu X, Zhang F, Ross-Degnan D, Wharam JF, Wagner AK. Intensity of End-of-Life Care in a Cohort of Commercially Insured Women With Metastatic Breast Cancer in the United States. JCO Oncol Pract. 2021 Feb; 17(2):e194-e203. PMID: 33170746.
  4. Leopold C, Haffajee RL, Lu CY, Wagner AK. The Complex Cancer Care Coverage Environment - What is the Role of Legislation? A Case Study from Massachusetts. J Law Med Ethics. 2020 09; 48(3):538-551. PMID: 33021165.
    Citations:    Fields:    
  5. Leopold C, Araujo-Lane C, Rosenberg C, Gilkey M, Wagner AK. Out-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program. Pharmacoecon Open. 2020 Jun; 4(2):389-392. PMID: 31325147.
    Citations: 1     
  6. Leopold C, Lu CY, Wagner AK. Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand. BMC Health Serv Res. 2020 Apr 25; 20(1):351. PMID: 32334579.
    Citations: 1     Fields:    Translation:Humans
  7. Gagne JJ, Popovic JR, Nguyen M, Sandhu SK, Greene P, Izem R, Jiang W, Wang Z, Zhao Y, Petrone AB, Wagner AK, Dutcher SK. Evaluation of Switching Patterns in FDA's Sentinel System: A New Tool to Assess Generic Drugs. Drug Saf. 2018 12; 41(12):1313-1323. PMID: 30120741.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  8. Garabedian LF, Sinaiko AD, Ross-Degnan D, Abu-Jaber T, Hoefer M, Oddleifson S, Wagner AK. Quality Reporting by Payers: A Mixed-Methods Study of Provider Perspectives and Practices. Qual Manag Health Care. 2018 Jul/Sep; 27(3):157-164. PMID: 29944628.
    Citations:    Fields:    Translation:Humans
  9. Leopold C, Peppercorn JM, Zafar SY, Wagner AK. Defining Value of Cancer Therapeutics-A Health System Perspective. J Natl Cancer Inst. 2018 07 01; 110(7):699-703. PMID: 29788313.
    Citations: 1     Fields:    Translation:Humans
  10. Leopold C, Wagner AK, Zhang F, Lu CY, Earle CC, Nekhlyudov L, Ross-Degnan D, Wharam JF. Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans. Breast Cancer Res Treat. 2018 Sep; 171(2):449-459. PMID: 29855813.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  11. Lu CY, Zhang F, Wagner AK, Nekhlyudov L, Earle CC, Callahan M, LeCates R, Xu X, Ross-Degnan D, Wharam JF. Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer. Breast Cancer Res Treat. 2018 Aug; 171(1):235-242. PMID: 29754304.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  12. Wharam JF, Zhang F, Lu CY, Wagner AK, Nekhlyudov L, Earle CC, Soumerai SB, Ross-Degnan D. Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment. J Clin Oncol. 2018 04 10; 36(11):1121-1127. PMID: 29489428.
    Citations: 13     Fields:    Translation:Humans
  13. Lu CY, Zhang F, Golonski N, Lupton C, Jeffrey P, Wagner AK. State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015. Value Health. 2018 06; 21(6):692-697. PMID: 29909874.
    Citations:    Fields:    Translation:Humans
  14. Morgan SG, Leopold C, Wagner AK. Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage. CMAJ. 2017 Jun 12; 189(23):E794-E799. PMID: 28606975.
    Citations: 8     Fields:    
  15. Leopold C, Morgan SG, Wagner AK. A rapidly changing global medicines environment: How adaptable are funding decision-making systems? Health Policy. 2017 Jun; 121(6):637-643. PMID: 28449884.
    Citations: 3     Fields:    Translation:Humans
  16. Leopold C, Wagner AK, Zhang F, Lu CY, Earle C, Nekhlyudov L, Ross-Degnan D, Wharam JF. Erratum to: Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer. Breast Cancer Res Treat. 2016 11; 160(2):385. PMID: 27696008.
    Citations:    Fields:    
  17. Leopold C, Wagner AK, Zhang F, Lu CY, Earle C, Nekhlyudov L, Ross-Degnan D, Wharam JF. Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer. Breast Cancer Res Treat. 2016 07; 158(2):333-40. PMID: 27342456.
    Citations: 3     Fields:    Translation:Humans
  18. Sruamsiri R, Wagner AK, Ross-Degnan D, Lu CY, Dhippayom T, Ngorsuraches S, Chaiyakunapruk N. Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis. BMJ Open. 2016 Mar 17; 6(3):e008671. PMID: 26988346.
    Citations: 4     Fields:    Translation:Humans
  19. Leopold C, Chambers JD, Wagner AK. Thirty Years of Media Coverage on High Drug Prices in the United States--A Never-Ending Story or a Time for Change? Value Health. 2016 Jan; 19(1):14-6. PMID: 26797230.
    Citations:    Fields:    Translation:Humans
  20. Hsu JC, Ross-Degnan D, Wagner AK, Zhang F, Lu CY. How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid? Clin Ther. 2015 Jul 01; 37(7):1420-1432.e1. PMID: 25976425.
    Citations: 5     Fields:    Translation:Humans
  21. Sruamsiri R, Ross-Degnan D, Lu CY, Chaiyakunapruk N, Wagner AK. Policies and programs to facilitate access to targeted cancer therapies in Thailand. PLoS One. 2015; 10(3):e0119945. PMID: 25798948.
    Citations: 6     Fields:    Translation:Humans
  22. Lu CY, Emmerick IC, Stephens P, Ross-Degnan D, Wagner AK. Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand. J Pharm Policy Pract. 2015; 8(1):7. PMID: 25815201.
    Citations: 3     
  23. Lu CY, Lupton C, Rakowsky S, Babar ZU, Ross-Degnan D, Wagner AK. Patient access schemes in Asia-pacific markets: current experience and future potential. J Pharm Policy Pract. 2015; 8(1):6. PMID: 25815200.
    Citations: 11     
  24. Vialle-Valentin CE, Serumaga B, Wagner AK, Ross-Degnan D. Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries. Health Policy Plan. 2015 Oct; 30(8):1044-52. PMID: 25255920.
    Citations: 23     Fields:    Translation:Humans
  25. Wagner AK, Quick JD, Ross-Degnan D. Quality use of medicines within universal health coverage: challenges and opportunities. BMC Health Serv Res. 2014 Aug 27; 14:357. PMID: 25164588.
    Citations: 14     Fields:    Translation:Humans
  26. Hsu JC, Lu CY, Wagner AK, Chan KA, Lai MS, Ross-Degnan D. Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: an interrupted time series study. Health Policy. 2014 Jun; 116(2-3):196-205. PMID: 24314624.
    Citations: 9     Fields:    Translation:Humans
  27. Fang Y, Wagner AK, Yang S, Jiang M, Zhang F, Ross-Degnan D. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China. Lancet Glob Health. 2013 Oct; 1(4):e227-37. PMID: 25104348.
    Citations: 32     Fields:    Translation:Humans
  28. Reddy SR, Ross-Degnan D, Zaslavsky AM, Soumerai SB, Wagner AK. Health care payments in the Asia Pacific: validation of five survey measures of economic burden. Int J Equity Health. 2013 Jul 03; 12:49. PMID: 23822552.
    Citations: 7     Fields:    Translation:Humans
  29. Wagner AK, Graves AJ, Fan Z, Walker S, Zhang F, Ross-Degnan D. Need for and access to health care and medicines: are there gender inequities? PLoS One. 2013; 8(3):e57228. PMID: 23505420.
    Citations: 4     Fields:    Translation:Humans
  30. Garabedian LF, Ross-Degnan D, Ratanawijitrasin S, Stephens P, Wagner AK. Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study. BMJ Open. 2012; 2(6). PMID: 23192243.
    Citations: 9     Fields:    
  31. Zhang F, Wagner AK, Ross-Degnan D. Simulation-based power calculation for designing interrupted time series analyses of health policy interventions. J Clin Epidemiol. 2011 Nov; 64(11):1252-61. PMID: 21640554.
    Citations: 46     Fields:    Translation:Humans
  32. Nekhlyudov L, Li L, Ross-Degnan D, Wagner AK. Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer. Breast Cancer Res Treat. 2011 Nov; 130(2):681-9. PMID: 21842245.
    Citations: 29     Fields:    Translation:Humans
  33. Wagner AK, Graves AJ, Reiss SK, Lecates R, Zhang F, Ross-Degnan D. Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey. Health Policy. 2011 May; 100(2-3):151-8. PMID: 20828854.
    Citations: 45     Fields:    Translation:Humans
  34. Briesacher BA, Ross-Degnan D, Wagner AK, Fouayzi H, Zhang F, Gurwitz JH, Soumerai SB. Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy. Med Care. 2010 Jun; 48(6):503-9. PMID: 20473197.
    Citations: 10     Fields:    Translation:Humans
  35. Ross-Degnan D, Pierre-Jacques M, Zhang F, Tadeg H, Gitau L, Ntaganira J, Balikuddembe R, Chalker J, Wagner AK. Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators. BMC Health Serv Res. 2010 Feb 19; 10:42. PMID: 20170478.
    Citations: 23     Fields:    Translation:Humans
  36. Zhang F, Wagner AK, Soumerai SB, Ross-Degnan D. Methods for estimating confidence intervals in interrupted time series analyses of health interventions. J Clin Epidemiol. 2009 Feb; 62(2):143-8. PMID: 19010644.
    Citations: 72     Fields:    Translation:Humans
  37. Bertoldi AD, Barros AJ, Wagner A, Ross-Degnan D, Hallal PC. A descriptive review of the methodologies used in household surveys on medicine utilization. BMC Health Serv Res. Published online 2008 October 31. doi: 10.1186/1472-6963-8-222. 2008.
  38. Vialle-Valentin C, Ross-Degnan D, Wagner AK. Medicine Coverage and Community-Based Health Insurance in Low-Income Countries. Health Res Policy Syst. Published online 2008 October 30. doi: 10.1186/1478-4505-6-11. 2008.
  39. Vialle-Valentin CE, Ross-Degnan D, Ntaganira J, Wagner AK. Medicines coverage and community-based health insurance in low-income countries. Health Res Policy Syst. 2008 Oct 30; 6:11. PMID: 18973675.
    Citations: 6     Fields:    
  40. Zhang F, Wagner AK, Soumerai SB, Ross-Degnan D. Methods for estimating confidence intervals in interrupted time series analyses of health interventions. Journal of Clinical Epidemiology. Epub ahead of print doi:10.1016/j.jclinepi.2008.08.007. 2008.
  41. Wagner AK, Valera M, Graves AJ, Laviña S, Ross-Degnan D. Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines. BMC Health Serv Res. 2008 Jul 29; 8:161. PMID: 18664285.
    Citations: 6     Fields:    Translation:Humans
  42. Wagner AK, Valera M, Graves AJ, Laviña S, Ross-Degnan D. Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines. BMC Health Serv Res. Published online 2008 July 29. doi: 10.1186/1472-6963-8-161. 2008.
  43. Wagner AK, Soumerai SB, Graves AJ, Briesacher B, Zhang F, Gurwitz J, Ross-Degnan D. Catastrophic expenses and lack of access to health care and medications among middle-aged Americans (submitted). 2008.
  44. Wagner AK, Ross-Degnan D . The potential for insurance systems to increase access to and appropriate use of medicines in Asia-Pacific countries. Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific. K. Eggleston, Editor, under review. 2008.
  45. Briesacher BA, Ross-Degnan D, Adams AS, Wagner AK, Gurwitz J, Soumerai SB. Redefining the affordability of medication expenditures among Medicaid enrollees. J Health and Soc Policy Review (in press). 2008.
  46. Bertoldi AD, Barros AJ, Wagner A, Ross-Degnan D, Hallal PC. Medicine access and utilization in a population covered by primary health care in Brazil. Health Policy. Epub ahead of print. doi:10.1016/j.healthpol.2008.07.001. 2008.
  47. Wagner AK, Ross-Degnan D, Gurwitz J, Soumerai SB. Benzodiazepines and hip fractures. Letter to the Editor. Ann Intern Med. 2007; 147(5):348.
  48. Wagner AK, Reiss S, Graves AJ, Ross-Degnan D. Results of feasibility study using World Health Survey data to measure medicines need, use, and out-of-pocket expenditures in eight low and lower-middle income countries. 2007.
  49. Wagner AK, Ross-Degnan D, Gurwitz JH, Zhang F, Gilden DB, Cosler L, Soumerai SB. Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med. 2007 Jan 16; 146(2):96-103. PMID: 17227933.
    Citations: 26     Fields:    Translation:Humans
  50. Wagner AK, Gandek B, Ware JE. SF-36 Health Survey: A Handbook for IQOLA Project Investigators. 2007.
  51. Wagner AK, Chan KA, Dashevsky I, Raebel MA, Andrade SE, Lafata JE, Davis RL, Gurwitz JH, Soumerai SB, Platt R. FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf. 2006 Jun; 15(6):369-86. PMID: 16294363.
    Citations: 19     Fields:    Translation:Humans
  52. Suttajit S, Tantipidoke R, Wagner AK, Ross-Degnan D, Sitthi-amorn C. Decisions about medication use by adults with respiratory infections in Bangkok slum communities: Implications for interventions to reduce antimicrobial resistance. Submitted. 2006.
  53. WHO Geneva, Department of Technical Cooperation on Essential Drugs and Traditional Medicines. Using Indicators to Measure Country Pharmaceutical Situations – Fact Book on WHO Level I and Level II Monitoring Indicators. World Health Organization: Geneva. 2006.
  54. Suttajit S, Wagner AK, Tantipidoke R, Ross-Degnan D, Sitthi-amorn C. Patterns, appropriateness, and predictors of antimicrobial prescribing for adults with upper respiratory infections in urban slum communities of Bangkok. Southeast Asian J Trop Med Public Health. 2005 Mar; 36(2):489-97. PMID: 15916061.
    Citations: 5     Fields:    Translation:Humans
  55. Simon SR, Chan KA, Soumerai SB, Wagner AK, Andrade SE, Feldstein AC, Lafata JE, Davis RL, Gurwitz JH. Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc. 2005 Feb; 53(2):227-32. PMID: 15673345.
    Citations: 22     Fields:    Translation:Humans
  56. Strassels SA, McNichol E, Wagner AK, Rogers WH, Gouveia WA, Carr DB. Persistent postoperative pain, health-realted quality of life, and functioning 1 month after hospital discharge. Acute Pain. 2004; 6(3-4):95-104.
  57. Wagner AK, Zhang F, Soumerai SB, Walker AM, Gurwitz JH, Glynn RJ, Ross-Degnan D. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med. 2004 Jul 26; 164(14):1567-72. PMID: 15277291.
    Citations: 53     Fields:    Translation:Humans
  58. Proceedings of the Second International Conference on Improving the Use of Medicines. Available at http://mednet3.who.int/icium/icium2004/proceedings.asp. 2004.
  59. Wagner AK, Soumerai SB, Zhang F, Mah C, Simoni-Wastila L, Cosler L, Fanning T, Gallagher P, Ross-Degnan D. Effects of state surveillance on new post-hospitalization benzodiazepine use. Int J Qual Health Care. 2003 Oct; 15(5):423-31. PMID: 14527986.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  60. Zhang F, Wagner AK, Soumerai S, Ross-Degnan D. Estimating confidence intervals around relative changes in outcomes in segmented regression analyses of time series data. 2002; 748-754.
  61. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002 Aug; 27(4):299-309. PMID: 12174032.
    Citations: 668     Fields:    Translation:Humans
  62. Wittink H, Hoskins Michel T, Wagner A, Sukiennik A, Rogers W. Deconditioning in patients with chronic low back pain: fact or fiction? Spine (Phila Pa 1976). 2000 Sep 01; 25(17):2221-8. PMID: 10973406.
    Citations: 13     Fields:    Translation:Humans
  63. Wittink H, Michel TH, Kulich R, Wagner A, Sukiennik A, Maciewicz R, Rogers W. Aerobic fitness testing in patients with chronic low back pain: which test is best? Spine (Phila Pa 1976). 2000 Jul 01; 25(13):1704-10. PMID: 10870147.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  64. Rogers W, Wittink H, Wagner A, Cynn D, Carr D. Assessing individual outcomes during outpatients' multidisciplinary chronic pain therapy by means of an augmentes SF-36. Pain Med. 2000; 1(1):44-54.
  65. Dworetzky BA, Hoch DB, Wagner AK, Salmanson E, Shanahan CW, Bromfield EB. The impact of a single seizure on health status and health care utilization. Epilepsia. 2000 Feb; 41(2):170-6. PMID: 10691113.
    Citations:    Fields:    Translation:Humans
  66. Wagner AK, Massaro FJ. Classification of donated drugs. An assessment of U.S. pharmaceutical donations: Players, processes, and products. Reich MR, ed. 1999.
  67. Wagner AK, Wyss K, Gandek B, Kilima PM, Lorenz S, Whiting D. A Kiswahili version of the SF-36 Health Survey for use in Tanzania: translation and tests of scaling assumptions. Qual Life Res. 1999; 8(1-2):101-10. PMID: 10457743.
    Citations: 18     Fields:    Translation:Humans
  68. Wyss K, Wagner AK, Whiting D, Mtasiwa DM, Tanner M, Gandek B, Kilima PM. Validation of the Kiswahili version of the SF-36 Health Survey in a representative sample of an urban population in Tanzania. Qual Life Res. 1999; 8(1-2):111-20. PMID: 10457744.
    Citations: 13     Fields:    Translation:HumansPHPublic Health
  69. Reich MR, Wagner AK, McLaughlin TJ, Dumbaugh KA, Derai-Cochin M. Pharmaceutical donations by the USA: an assessment of relevance and time-to-expiry. Bull World Health Organ. 1999; 77(8):675-80. PMID: 10516789.
    Citations:    Fields:    
  70. Wagner AK, Gandek B, Aaronson NK, Acquadro C, Alonso J, Apolone G, Bullinger M, Bjorner J, Fukuhara S, Kaasa S, Leplège A, Sullivan M, Wood-Dauphinee S, Ware JE. Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998 Nov; 51(11):925-32. PMID: 9817109.
    Citations: 74     Fields:    Translation:Humans
  71. Wagner AK. The social determinants of health working group report. Robert Wood Johnson Foundation Investigator Awards in Health Policy Program. 1998.
  72. Wagner AK. A description by a care provider, contributed to: Schachter SC, Rowan AJ. The brainstorms healer. Epilepsy in our experience. Stories of health care professionals as care providers and patients. 1998.
  73. Wagner AK, Ehrenberg BL, Tran TA, Bungay KM, Cynn DJ, Rogers WH. Patient-based health status measurement in clinical practice: a study of its impact on epilepsy patients' care. Qual Life Res. 1997 May; 6(4):329-41. PMID: 9248315.
    Citations: 20     Fields:    Translation:HumansCTClinical Trials
  74. Wagner AK. Using patient-based assessments for individual patient care. Pharmacoeconomics and outcomes: Applications for patient care. Bungay KM, Osterhaus JT, Paladino JA, Sanchez LA, eds. 1997; 363-416.
  75. Wagner AK, Shea CC, Sant G. Health-related quality of life issues. Interstitial Cystitis. Sant G, ed. 1997; 261-270.
  76. Wagner AK, Bungay KM, Kosinski M, Bromfield EB, Ehrenberg BL. The health status of adults with epilepsy compared with that of people without chronic conditions. Pharmacotherapy. 1996 Jan-Feb; 16(1):1-9. PMID: 8700786.
    Citations: 6     Fields:    Translation:Humans
  77. Bungay KM, Wagner AK. Introduction to pharmacist participation in measuring and monitoring patients' health-related quality of life. Am J Health Syst Pharm. 1995 Jul 15; 52(14 Suppl 3):S19-23. PMID: 7552913.
    Citations:    Fields:    Translation:Humans
  78. Wagner AK, Bungay KM, Bromfield EB, Ehrenberg BL. Assessing the health status of adult patients with epilepsy. Am J Health Syst Pharm. 1995 Jul 15; 52(14 Suppl 3):S29-31. PMID: 7552916.
    Citations:    Fields:    Translation:Humans
  79. Wagner AK, Vickrey BG. The routine use of health-related quality of life measures in the care of patients with epilepsy: rationale and research agenda. Qual Life Res. 1995 Apr; 4(2):169-77. PMID: 7780383.
    Citations: 9     Fields:    Translation:Humans
  80. Wagner AK, Keller SD, Kosinski M, Baker GA, Jacoby A, Hsu MA, Chadwick DW, Ware JE. Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life. Qual Life Res. 1995 Apr; 4(2):115-34. PMID: 7780379.
    Citations: 21     Fields:    Translation:Humans
  81. Bungay KM, Wagner AK. Comment: assessing the quality of pharmaceutical care. Ann Pharmacother. 1993 Dec; 27(12):1542-3. PMID: 8305795.
    Citations: 1     Fields:    Translation:Humans
  82. Wagner AK. Assessing the health-related quality of life of people with epilepsy. International Epilepsy News. 1993; 27(114):12-14 (letter).
  83. Wagner AK. International Quality of Life Assessment (IQOLA)Project. Quality of Life Newsletter. 1992; 3:5.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Wagner's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (235)
Co-Authors (28)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.